ATE167398T1 - Behandlungsverfahren für therapiewiderstehende schizophrenie mit amperozide - Google Patents
Behandlungsverfahren für therapiewiderstehende schizophrenie mit amperozideInfo
- Publication number
- ATE167398T1 ATE167398T1 AT91905529T AT91905529T ATE167398T1 AT E167398 T1 ATE167398 T1 AT E167398T1 AT 91905529 T AT91905529 T AT 91905529T AT 91905529 T AT91905529 T AT 91905529T AT E167398 T1 ATE167398 T1 AT E167398T1
- Authority
- AT
- Austria
- Prior art keywords
- therapy
- amperocides
- treatment methods
- resistant schizophrenia
- schizophrenia
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 201000000980 schizophrenia Diseases 0.000 title abstract 2
- NNAIYOXJNVGUOM-UHFFFAOYSA-N amperozide Chemical compound C1CN(C(=O)NCC)CCN1CCCC(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 NNAIYOXJNVGUOM-UHFFFAOYSA-N 0.000 abstract 1
- 229950000388 amperozide Drugs 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/487,547 US5013735A (en) | 1990-03-01 | 1990-03-01 | Method of treating therapy-resistant schizophrenia with amperozide (N-ethyl-4-(4',4'-bis(p-fluorophenyl)butyl)-1-piperazine-carboxamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE167398T1 true ATE167398T1 (de) | 1998-07-15 |
Family
ID=23936183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91905529T ATE167398T1 (de) | 1990-03-01 | 1991-02-27 | Behandlungsverfahren für therapiewiderstehende schizophrenie mit amperozide |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5013735A (de) |
| EP (1) | EP0517787B1 (de) |
| JP (1) | JP3243514B2 (de) |
| AT (1) | ATE167398T1 (de) |
| DE (1) | DE69129623T2 (de) |
| DK (1) | DK0517787T3 (de) |
| ES (1) | ES2117008T3 (de) |
| WO (1) | WO1991012805A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5300422A (en) * | 1991-12-04 | 1994-04-05 | Case Western Reserve University | Screening method for controlling agranulocytosis |
| GB0306604D0 (en) * | 2003-03-21 | 2003-04-30 | Curidium Ltd | Second medical use |
| US20080076924A1 (en) * | 2006-06-30 | 2008-03-27 | Patrick Betschmann | Piperazines as P2X7 antagonists |
| US20080139573A1 (en) * | 2006-12-08 | 2008-06-12 | Copharm | Treatment of resistant Schizophrenia and other CNS disorders |
| JP7321114B2 (ja) * | 2019-04-26 | 2023-08-04 | ユニ・チャーム株式会社 | 吸収性物品用の流動体の配置方法及び吸収性物品 |
-
1990
- 1990-03-01 US US07/487,547 patent/US5013735A/en not_active Expired - Lifetime
-
1991
- 1991-02-27 DK DK91905529T patent/DK0517787T3/da active
- 1991-02-27 EP EP91905529A patent/EP0517787B1/de not_active Expired - Lifetime
- 1991-02-27 AT AT91905529T patent/ATE167398T1/de not_active IP Right Cessation
- 1991-02-27 JP JP50533591A patent/JP3243514B2/ja not_active Expired - Fee Related
- 1991-02-27 DE DE69129623T patent/DE69129623T2/de not_active Expired - Fee Related
- 1991-02-27 WO PCT/SE1991/000161 patent/WO1991012805A1/en not_active Ceased
- 1991-02-27 ES ES91905529T patent/ES2117008T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69129623D1 (de) | 1998-07-23 |
| DK0517787T3 (da) | 1999-04-06 |
| EP0517787A1 (de) | 1992-12-16 |
| ES2117008T3 (es) | 1998-08-01 |
| US5013735A (en) | 1991-05-07 |
| JPH05504957A (ja) | 1993-07-29 |
| JP3243514B2 (ja) | 2002-01-07 |
| DE69129623T2 (de) | 1998-12-17 |
| WO1991012805A1 (en) | 1991-09-05 |
| EP0517787B1 (de) | 1998-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69535498D1 (de) | Verfahren zur behandlung vaskulärer kopfschmerzen | |
| LV10048A (lv) | Lidzeklis slimibu arstesanai un ta iegusanas process | |
| DE69523350D1 (de) | Behandlung von hyperproliferativen Gefässerkrankungen | |
| FR10C0016I2 (fr) | Procedes et compositions s'appliquant au traitement de la glomerulonephrite | |
| KR890701107A (ko) | 알쯔하이머 병 치료용 화합물들 | |
| LU91271I2 (fr) | Natalizumab et ses dérivés pharmaceutiquement acceptables (TYSABRI) | |
| DK0637238T3 (da) | Behandling af makuløs degenerering | |
| ATE116550T1 (de) | Behandlung von neoplastischen krankenheiten mit interleukin-10. | |
| DE3888273D1 (de) | Medizinischer Apparat zur Behandlung mit Ultraschall. | |
| ATE331527T1 (de) | Verfahren zur behandlung von brustdrüsenerkrankungen | |
| ATE166230T1 (de) | Verwendung von anti-icam antikörpern zur herstellung eines präparats für die behandlung von endotoxinschock | |
| ATE152621T1 (de) | Behandlungsverfahren kataboler dysfunktion | |
| FI960748A0 (fi) | Antipsykoottinen menetelmä | |
| DE69300321D1 (de) | Behandlung neurodegenerativer Erkrankungen. | |
| DE3854121D1 (de) | Arzneimittelzusammensetzungen zur behandlung von psoriasis. | |
| DE69129623D1 (de) | Behandlungsverfahren für therapiewiderstehende schizophrenie mit amperozide | |
| IT1224144B (it) | Procedimento per il trattamento dei tessili | |
| DK0445280T3 (da) | Terapeutisk middel og fremgangsmåde til inhibering af vaskularisering af tumorer | |
| ATE239470T1 (de) | Melatonin-derivate zur verwendung in der behandlung von desynchronisierungs-erkankungen | |
| DE3268024D1 (en) | 0-alkyl-0-carbamoyl-glycero-phospho-cholines and process for their preparation | |
| DE69736180D1 (de) | Behandlung von manischen erkrankungen | |
| ATE149840T1 (de) | Behandlung von leberkrebs | |
| IE811612L (en) | Thiazoles | |
| DE69307702D1 (de) | Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit | |
| NO990436L (no) | FremgangsmÕte for behandling av bipolar forstyrrelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |